Organovo Holdings, Inc.
ONVO
주식 순위
#36033
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
주가
$2.00
마지막 동기화: 2025-05-19
시가총액
$2.93M
변동 (1일)
-3.38%
변동 (1년)
656.14%
국가
US
거래 Organovo Holdings, Inc. (ONVO)
카테고리
Healthcare
Organovo Holdings, Inc. (ONVO)의 주가 이력
최고 종가: $5.13 (2025-03-01 기준)
최저 종가: $131.45 (2014-11-01 기준)
최저 종가: $131.45 (2014-11-01 기준)
Organovo Holdings, Inc.의 주가 이력 (2014 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2025 | 6.61% |
| 2024 | -65.68% |
| 2023 | -24.35% |
| 2022 | -61.52% |
| 2021 | -70.29% |
| 2020 | -31.30% |
| 2019 | -29.19% |
| 2018 | 153.68% |
| 2014 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.77 | -3.82% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
